Contemporary Issues in Lung CancerJones & Bartlett Publishers, 2009 M02 12 - 364 pages In the United States, lung cancer is the second most commonly diagnosed cancer and the leading cause of cancer death. Even more devastating is its five-year survival rate of only 15.8%. Despite these dismal facts, lung cancer receives little national attention and research and funding for lung cancer lags behind other cancers. The intent of Contemporary Issues in Lung Cancer: A Nursing Perspective Second Edition is to provide oncology nurses and healthcare professionals with in-depth information on the issues that surround this disease, so that they might impact both education and research and provide better care for their patients. |
From inside the book
Results 1-5 of 80
Page xi
... Oncology Dana Farber Cancer Institute Boston, Massachusetts Doris Dickerson ... Oncology Asheville, North Carolina Mary Lou Heater, MSN, CNS, APRN-BC Advanced Practice Nurse The University of Texas M.D. ... Clinical Trials xi Contributors.
... Oncology Dana Farber Cancer Institute Boston, Massachusetts Doris Dickerson ... Oncology Asheville, North Carolina Mary Lou Heater, MSN, CNS, APRN-BC Advanced Practice Nurse The University of Texas M.D. ... Clinical Trials xi Contributors.
Page xii
... Clinical Trials Office University of Florida Shands Cancer Center Gainesville, Florida Kenneth R. Olivier, MD Associate Consultant Radiation Oncology Mayo Clinic Rochester, Minnesota Karin Olson, PhD, RN Faculty of Nursing University of ...
... Clinical Trials Office University of Florida Shands Cancer Center Gainesville, Florida Kenneth R. Olivier, MD Associate Consultant Radiation Oncology Mayo Clinic Rochester, Minnesota Karin Olson, PhD, RN Faculty of Nursing University of ...
Page 14
... oncology: Management decisions (2nd ed., pp. 303–320). Philadelphia: Lippincott Williams & Wilkins. Edling, C ... Clinical Oncology, 24(31), 5079–5090. Hirsch, R., Matthews, M., Aisner, S., Campobasso, O., Elema, J., Gazdar, A., et al ...
... oncology: Management decisions (2nd ed., pp. 303–320). Philadelphia: Lippincott Williams & Wilkins. Edling, C ... Clinical Oncology, 24(31), 5079–5090. Hirsch, R., Matthews, M., Aisner, S., Campobasso, O., Elema, J., Gazdar, A., et al ...
Page 21
... Clinical Oncology. The expression of several growth factors has been identified in lung cancer or in the sur- rounding tissue, leading to a series of autocrine and paracrine growth stimulation for the development of lung cancer (Wistuba ...
... Clinical Oncology. The expression of several growth factors has been identified in lung cancer or in the sur- rounding tissue, leading to a series of autocrine and paracrine growth stimulation for the development of lung cancer (Wistuba ...
Page 31
You have reached your viewing limit for this book.
You have reached your viewing limit for this book.
Contents
Oncology Treatment Modalities | 45 |
Special Issues Facing Individuals with Lung Cancer | 117 |
Psychosocial Issues of Individuals with Lung Cancer | 231 |
Assistance and Resources for Individuals Facing Lung Cancer | 255 |
Media and Future Research Directions | 301 |
Index | 353 |
Other editions - View all
Common terms and phrases
adjuvant agents aprepitant associated bevacizumab breathing breathlessness Bruera carboplatin carcinoma cell lung cancer chemotherapy chronic cisplatin Clinical Oncology clinical trials combination diagnosis disease docetaxel dose drug dyspnea EGFR erlotinib etoposide evaluation evidence-based factors fatigue gefitinib gemcitabine gene improve increased individuals indoor radon Internet intervention irinotecan Journal of Clinical lung cancer patients Medicine ment metastatic months NCCN nicotine non-small cell lung NSCLC Nursing Forum Oncology Nursing Oncology Nursing Forum paclitaxel palliative palliative care patient navigation patients and families patients with lung pemetrexed phase postoperative potential pulmonary quit smoking radiation therapy radiotherapy radon randomized receptors regimen reported resection respiratory response rate risk role SCLC score screening Sekido side effects small cell lung smoking cessation stage strategies support group surgical survival rate Symptom Management Table tients tion tobacco topotecan toxicity treat treatment tumor versus vinorelbine weight loss